Earnings Release

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

 

FORM 8-K

 

 

Current Report Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

 

Date of Report (Date of earliest event reported): April 22, 2003

 

 

 

 

Seattle Genetics, Inc.

(Exact name of Registrant as specified in its charter)

 

 

Delaware

  

0-32405

  

91-1874389

(State or other jurisdiction of

incorporation)

  

(Commission File Number)

  

(I.R.S. Employer Identification No.)

 

 

21823 30th Drive SE

Bothell, Washington 98021

(Address of principal executive offices, including zip code)

 

 

(425) 527-4000

(Registrant’s telephone number, including area code)

 

 

 

Item 7. Financial Statements and Exhibits.

 

(c) Exhibits.

 

99.1

   

Press Release of Seattle Genetics, Inc. dated April 22, 2003 (financial results for the first quarter of 2003).

 

Item 9. Regulation FD Disclosure.

 

In accordance with SEC Release No. 33-8216, the following information, which is intended to be furnished under Item 12, “Results of Operations and Financial Condition,” is instead being furnished under Item 9, “Regulation FD Disclosure.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

On April 22, 2003, Seattle Genetics, Inc. issued a press release announcing financial results for the quarter ended March 31, 2003. A copy of the press release is attached as Exhibit 99.1 hereto and incorporated into this Form 8-K by reference.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

       

SEATTLE GENETICS, INC.

Date: April 22, 2003

      

By:

  

/S/    CLAY B. SIEGALL

           

Clay B. Siegall

President and Chief Executive Officer

 

INDEX TO EXHIBITS

 

Exhibit No.

   

Description

99.1

   

Press Release of Seattle Genetics, Inc. dated April 22, 2003 (financial results for the first quarter of 2003).